Maselli Misure S.p.A. listed on sarcoma ransomware leak site
Maselli Misure S.p.A. has been listed on the leak site of the sarcoma ransomware group, which claims to possess 49 GB of data.
- Published
- 3 min read
- 3 min read
- Ransomware group: sarcoma
- Country: Italy
- Sector: Technology
- Announcement date: August 15, 2025
Maselli Misure S.p.A. targeted by sarcoma ransomware group
The Italian technology firm Maselli Misure S.p.A. has been listed on the leak site of the sarcoma ransomware group. According to the announcement made by the threat actor, the group claims to be in possession of a significant amount of data belonging to the organization.
Details of the claimed attack
The threat actor known as sarcoma has published a listing on its leak site involving Maselli Misure S.p.A. The announcement, which was made on August 15, 2025, claims that the group has acquired a 49 GB archive containing data allegedly belonging to the company. While the threat actor has made these claims, the specific details regarding the nature of the intrusion have not been provided.
Ransomware groups often utilize leak sites as a tool for double extortion. In these scenarios, attackers not only encrypt an organization's systems to disrupt operations but also threaten to release sensitive information on public platforms to pressure the victim into paying a ransom. The publication of a listing on such a site is a common tactic used to damage an organization's reputation and increase the pressure on the target.
Content and affected data types
The information provided by the threat actor suggests that the leaked data consists of specific file types and database records. However, because no screenshots were provided with the announcement, detailed information regarding the specific content of the files remains unavailable. The listing identifies the following types of affected data:
- Files
- SQL database records
The presence of SQL records is particularly noteworthy in cyberattacks, as these often contain structured information from corporate databases. Such data can include sensitive business information or customer details, depending on the specific database targeted during the breach.
Organization profile: Maselli Misure S.p.A.
Maselli Misure S.p.A. is an Italian family-owned company with a long history in the technology sector. For over 70 years, the company has been involved in the design and manufacture of optical technology used for in-line and laboratory quality control analysis. Their products serve critical industries, including the food and beverage, pharmaceutical, and chemical sectors. Through a global network, the company provides high-precision analytical measurement instruments designed for various industrial processes.
Potential impact and industry implications
This incident may negatively impact the operational continuity and commercial reputation of Maselli Misure S.p.A. The claim that SQL-based data has been taken suggests a potential risk of exposure for corporate databases or customer information. Furthermore, because the institution is based in Italy, a potential data breach could lead to legal processes and sanctions under the GDPR (EU General Data Protection Regulation).
Beyond legal and regulatory risks, the leaked data could potentially be used by malicious actors for identity theft or targeted phishing attacks. In such attacks, stolen information is used to craft highly convincing messages to deceive employees or customers, further compromising the security of the organization and its partners.
For organizations operating in high-precision technology and industrial sectors, maintaining robust cybersecurity measures is essential. Defensive strategies often include implementing multi-factor authentication, maintaining regular offline backups, and conducting regular security audits to identify vulnerabilities. Additionally, monitoring for unauthorized access to SQL databases and implementing strict data loss prevention (DLP) measures can help mitigate the risks associated with data exfiltration. Information regarding the sarcoma group remains limited in the public domain.